首页> 外文期刊>Arthritis & Rheumatism >Therapeutic potential of anti–interleukin-17A aptamer: Suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models
【24h】

Therapeutic potential of anti–interleukin-17A aptamer: Suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models

机译:抗白介素17A适体的治疗潜力:两种小鼠模型中白介素17A信号的抑制和自身免疫性的减弱

获取原文
获取原文并翻译 | 示例
           

摘要

The proinflammatory cytokine interleukin-17A (IL-17A) is produced primarily by the CD4+ T cell subset called Th17 cells, which is involved in host defense, inflammation, and autoimmune disorders. This study was undertaken to investigate the effect of a high-affinity RNA molecule, called an aptamer, against human IL-17A on IL-17A–induced signal transduction in vitro and its anti-autoimmune efficacy in vivo in 2 mouse models of inflammation.
机译:促炎细胞因子白介素-17A(IL-17A)主要由称为Th17细胞的CD4 + T细胞亚群产生,它参与宿主防御,炎症和自身免疫性疾病。这项研究旨在研究一种高亲和力的RNA分子(适体)对人IL-17A的体外IL-17A诱导的信号转导的作用及其在2种炎症小鼠体内的抗自身免疫效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号